Arcellx, Inc. – NASDAQ:ACLX
Arcellx stock price today
$72
-7.07
-8.95%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 14 hours
Arcellx stock price monthly change
+26.67%
month
Arcellx stock price quarterly change
+26.67%
quarter
Arcellx stock price yearly change
+37.32%
year
Arcellx key metrics
Market Cap | 4.05B |
Enterprise value | 1.07B |
P/E | -5.57 |
EV/Sales | N/A |
EV/EBITDA | -4.30 |
Price/Sales | N/A |
Price/Book | 5.10 |
PEG ratio | -0.40 |
EPS | -1.07 |
Revenue | 131.66M |
EBITDA | -66.94M |
Income | -50.54M |
Revenue Q/Q | 119.16% |
Revenue Y/Y | 635.05% |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -50.84% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeArcellx stock price history
Arcellx stock forecast
Arcellx financial statements
Average Price Target
$111.6
Potential upside: 54.99%
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 14.30M | -23.85M | -166.79% |
|---|---|---|---|
| Sep 2023 | 14.95M | -39.33M | -262.99% |
| Dec 2023 | 63.14M | 19.84M | 31.42% |
| Mar 2024 | 39.25M | -7.19M | -18.34% |
| 2023-11-13 | -0.56 | -0.81 |
|---|---|---|
| 2024-02-28 | -0.61 | 0.42 |
| 2024-05-09 | -0.51 | -0.14 |
| Jun 2023 | 623528000 | 329.86M | 52.9% |
|---|---|---|---|
| Sep 2023 | 614218000 | 348.09M | 56.67% |
| Dec 2023 | 825132000 | 339.75M | 41.18% |
| Mar 2024 | 779695000 | 283.12M | 36.31% |
| Jun 2023 | -22.61M | 51.27M | 116K |
|---|---|---|---|
| Sep 2023 | -10.10M | -160.02M | -4.98M |
| Dec 2023 | 58.24M | 21.01M | 188.59M |
| Mar 2024 | -31.90M | -206.81M | -2.98M |
Arcellx alternative data
| Sep 2023 | 98 |
|---|---|
| Oct 2023 | 98 |
| Nov 2023 | 98 |
| Dec 2023 | 98 |
| Jan 2024 | 98 |
| Feb 2024 | 98 |
| Mar 2024 | 130 |
| Apr 2024 | 130 |
| May 2024 | 130 |
| Jun 2024 | 130 |
| Jul 2024 | 130 |
Arcellx other data
45.96%
-49.60%
of ACLX is owned by hedge funds
57
-66
16.70M
-25.16M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Jan 2024 | 0 | 45185 |
| Feb 2024 | 0 | 48176 |
| Mar 2024 | 0 | 566903 |
| Apr 2024 | 0 | 32488 |
| May 2024 | 0 | 30289 |
| Jul 2024 | 0 | 39352 |
| Aug 2024 | 0 | 48634 |
| Sep 2024 | 0 | 47372 |
| Oct 2024 | 0 | 3000 |
| Nov 2024 | 0 | 73094 |
| Dec 2024 | 0 | 3000 |
Arcellx: Anito-Cel With D-Domain Differentiation Looks To Capture R/R MM Market
Baron Health Care Fund Q1 2025 Top Net Purchases And Sales
Baron Health Care Fund Q1 2025 Top Contributors And Detractors
Arcellx's Strategic Moves With Anito-Cel Aim To Disrupt Myeloma Market
Arcellx: Navigating The CAR T-Cell Revolution
Arcellx: A Strong Contender In The CAR-T Multiple Myeloma Market
Legend Biotech: Working On Supply Issues
Arcellx: The Gilead Deal Derisks And Proves Their Technology
2seventy bio: This Spinoff In The CAR-T Space Is Attractive
-
What's the price of Arcellx stock today?
One share of Arcellx stock can currently be purchased for approximately $72.
-
When is Arcellx's next earnings date?
Unfortunately, Arcellx's (ACLX) next earnings date is currently unknown.
-
Does Arcellx pay dividends?
No, Arcellx does not pay dividends.
-
How much money does Arcellx make?
Arcellx has a market capitalization of 4.05B. Arcellx made a loss 70.69M US dollars in net income (profit) last year or -$0.14 on an earnings per share basis.
-
What is Arcellx's stock symbol?
Arcellx, Inc. is traded on the NASDAQ under the ticker symbol "ACLX".
-
What is Arcellx's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Arcellx?
Shares of Arcellx can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Arcellx have?
As Jul 2024, Arcellx employs 130 workers.
-
When Arcellx went public?
Arcellx, Inc. is publicly traded company for more then 3 years since IPO on 4 Feb 2022.
-
What is Arcellx's official website?
The official website for Arcellx is arcellx.com.
-
Where are Arcellx's headquarters?
Arcellx is headquartered at 25 West Watkins Mill Road, Gaithersburg, MD.
-
How can i contact Arcellx?
Arcellx's mailing address is 25 West Watkins Mill Road, Gaithersburg, MD and company can be reached via phone at +240 3270603.
-
What is Arcellx stock forecast & price target?
Based on 5 Wall Street analysts` predicted price targets for Arcellx in the last 12 months, the avarage price target is $111.6. The average price target represents a 54.99% change from the last price of $72.
Arcellx company profile:
Arcellx, Inc.
arcellx.comExchange:
NASDAQ
Full time employees:
130
Industry:
Biotechnology
Sector:
Healthcare
Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It is also developing ACLX-001, an immunotherapeutic combination composed of ARC-T cells and bi-valent SparX proteins targeting BCMA to treat r/r MM; ACLX-002 and ACLX-003 for treating r/r acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS); and other AML/MDS product candidates, as well as solid tumor programs. The company was formerly known as Encarta Therapeutics, Inc. and changed its name to Arcellx, Inc. in January 2016. Arcellx, Inc. was incorporated in 2014 and is headquartered in Gaithersburg, Maryland.
25 West Watkins Mill Road
Gaithersburg, MD 20878
Gaithersburg, MD 20878
CIK: 0001786205
ISIN: US03940C1009
CUSIP: 03940C100
